Imexpharm’s EBITDA margin rises to 22.3 per cent driven by cost management and growth
October 22, 2025 | 08:58
In September 2025, Imexpharm’s profit before tax surged by 101 per cent, while EBITDA increased by 48 per cent.
Imexpharm announces third quarter results
October 19, 2024 | 10:53
On October 18, Imexpharm Corporation announced its third quarter results.
Eisai Vietnam opens new office and enters strategic partnership
May 14, 2022 | 13:08
On May 12, Eisai Vietnam announced the opening of its new office and signed a four-year cooperation relationship with the Vietnam Association of Neurology.
Mobile Version